ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : AstraZeneca


Include trials that are no longer recruiting patients.

41 studies were found.
1.RecruitingArimidex in McCune Albright Syndrome
Condition: McCune-Albright Syndrome
2.RecruitingAZD5438 in Patients with Advanced Solid Malignancies
Condition: advanced, solid, malignancies
3.No longer recruitingCAFE Comparison of Atypicals in First Episode
Conditions: Schizophrenia; Psychotic Disorders; Mental Health; Mental Disorders
4.RecruitingComparison of Nolvadex 20 mg and placebo combination to Nolvadex 20 mg and ZD1839 (IRESSA™) 250 mg combination in patients with metastatic breast cancer and estrogen receptor (ER) and/or progesterone (PR) positive tumours
Condition: Breast Neoplasms
5.CompletedA comparison of Seroquel vs. Risperidone in Schizophrenia
Condition: Schizophrenia
6.RecruitingConfirmatory Study of Seroquel® in the Treatment of Bipolar Depression
Condition: Bipolar Disorder
7.No longer recruitingEfficacy Study of 6474 to treat Multiple Myeloma Cancer
Condition: Multiple Myeloma
8.RecruitingEnoximone Plus Extended-Release Metoprolol Succinate in Subjects with Advanced Chronic Heart Failure
Condition: Heart Failure, Congestive
9.RecruitingEsomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
Condition: Zollinger-Ellison Syndrome
10.SuspendedExploratory Study to Assess the Biological Activity of ZD6126 in Subjects with Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
Conditions: Carcinoma, Renal Cell; Kidney Neoplasms
11.RecruitingFASLODEX and AROMASIN in Hormone Receptor Positive Postmenopausal Women with Advanced Breast Cancer
Conditions: Breast Neoplasms; Metastases, Neoplasm
12.RecruitingFulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women with Estrogen Receptor Positive Breast Cancer
Condition: Breast Cancer
13.No longer recruitingIressa Expanded Access Program (EAP)
Conditions: Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm
14.TerminatedIressa/Docetaxel in Non-Small-Cell Lung Cancer
Condition: Non-small cell lung cancer
15.Not yet recruitingMaintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
16.RecruitingOral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
17.Not yet recruitingPediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis (BATT)]
Condition: Puberty, Precocious
18.No longer recruitingA Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 Given Orally Once Daily in Subjects with Metastatic Prostate Cancer
Conditions: Prostatic Neoplasms; Metastases, Neoplasm
19.RecruitingQuetiapine Fumarate (SEROQUEL) and Placebo in the Treatment of Acutely Ill Patients with Schizophrenia
Condition: Schizophrenia
20.RecruitingQuetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients with Schizophrenia
Condition: Schizophrenia
21.RecruitingQuetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children and Adolescent Patients with Bipolar I Mania
Condition: Bipolar Disorder
22.CompletedReversal of Ventricular Remodeling with Toprol-XL
Condition: Heart Failure, Congestive
23.RecruitingRisedronate Sodium on Bone in Postmenopausal Women with Hormone-Receptor-Positive Early Breast Cancer
Condition: Breast Cancer
24.RecruitingSafety and Effectiveness of NXY-059 for the Treatment of Patients who have Suffered from a Stroke
Conditions: Cerebral Stroke; Stroke, Acute; Cerebrovascular Stroke; Ischemic Attack, Transient
25.CompletedSafety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients with Bipolar Depression
Conditions: Bipolar Disorder; Depression, Bipolar
26.Not yet recruitingSafety of NXY-059 for the Treatment of Patients who have Suffered from a Stroke
Condition: Intracerebral Hemorrhage
27.TerminatedSafety, Tolerability and Efficacy of ZD6126 in Combination with Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects with Metastatic Colorectal Cancer.
Conditions: Colorectal Neoplasms; Metastases, Neoplasm
28.RecruitingSeroquel plus Mood Stabilizer Compared to Placebo plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
Condition: Bipolar Disorder
29.RecruitingStudy Of Zd1839 (Iressa™) Versus Methotrexate For Previously Treated Patients With Squamous Cell Carcinoma Of The Head And Neck
Conditions: Carcinoma, Squamous Cell; Neoplasms, Squamous Cell; Head and Neck Neoplasms
30.RecruitingA study to determine if antibiotics prevent infection in the pancreas of patients where part of the pancreas has died.
Condition: Pancreatitis, Acute Necrotizing
31.RecruitingTherapy with docetaxel and ZD1839 for Patients who have advanced breast cancer
Condition: Breast Neoplasms
32.No longer recruitingThis study is to assess the efficacy and safety of ZD6474 in subjects with metastatic breast cancer
Conditions: Breast Neoplasms; Metastases, Neoplasm
33.CompletedThis study is to assess the efficacy and safety of ZD6474 in subjects with Non-small cell lung cancer.
Conditions: Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm
34.CompletedThis study is to compare the efficacy of ZD6474 and ZD1839 in subjects with NSCLC.
Condition: Carcinoma, Non-Small-Cell Lung
35.RecruitingTrial Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients with Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) Metastatic Breast Cancer
Condition: Breast Cancer
36.No longer recruitingVentilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support
Condition: Pneumonia
37.No longer recruitingZD1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; Quality of Life
38.No longer recruitingZD1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
39.RecruitingZD4054 in Pain-free or Mildly symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)
Condition: Prostate Cancer
40.RecruitingZD6474 Alone or in Combination with Paclitaxel and Carboplatin in Subjects with Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
41.CompletedZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act